| For: | Lee SJ, Song SY, Kim MK, Na HG, Bae CH, Kim YD, Choi YS. Complete response of metastatic BRAF V600-mutant anaplastic thyroid cancer following adjuvant dabrafenib and trametinib treatment: A case report. World J Clin Cases 2023; 11(27): 6664-6669 [PMID: 37900238 DOI: 10.12998/wjcc.v11.i27.6664] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v11/i27/6664.htm |
| Number | Citing Articles |
| 1 |
Robert Bränström, Henrik Andersson, Martin Hysek, David Goldstein, Andreas Ekborn, Ivan Shabo. Complete response of lymph node metastasis following adjuvant dabrafenib and trametinib treatment for BRAF V600-mutant anaplastic thyroid cancer – case report. International Journal of Surgery Case Reports 2026; doi: 10.1097/RC9.0000000000000587
|
| 2 |
Ningxin Wang, Yuying Chen, Guhan Luo, Dingcun Luo. From mechanisms to markers: role of pyroptosis in revolutionizing thyroid cancer care. Cell Death Discovery 2025; 11(1) doi: 10.1038/s41420-025-02741-0
|
| 3 |
Alessandro Prete, Antonio Matrone, Roberto Plebani. State of the Art in 3D Culture Models Applied to Thyroid Cancer. Medicina 2024; 60(4) doi: 10.3390/medicina60040520
|
| 4 |
Francesca Gorini, Alessandro Tonacci. Vitamin C in the Management of Thyroid Cancer: A Highway to New Treatment?. Antioxidants 2024; 13(10) doi: 10.3390/antiox13101242
|